Ja. Bennett et al., SIMILARITY BETWEEN NATURAL AND RECOMBINANT HUMAN ALPHA-FETOPROTEIN ASINHIBITORS OF ESTROGEN-DEPENDENT BREAST-CANCER GROWTH, Breast cancer research and treatment, 45(2), 1997, pp. 169-179
Alpha-fetoprotein (AFP) isolated from rodent amniotic fluid or human c
ord sera, upon incubation with a molar excess of estradiol, is convert
ed to a form which inhibits estrogen-stimulated tissue growth. The pur
pose of this study was to determine whether recombinant human AFP prod
uced in an E. coli expression system retained this function. The recom
binant protein was similar to the natural protein isolated from pooled
human cord sera in all functional aspects evaluated. It was detected
by monoclonal and polyclonal antibodies to the natural protein. Follow
ing exposure to estradiol, it was converted to an inhibitor of estroge
n-stimulated growth of immature mouse uterus yielding a dose/response
curve similar to that of the natural protein. It inhibited the growth
of estrogen-dependent (MCF-7) but not estrogen-independent (MDA-MB-231
) breast cancer xenografts with the same schedule dependency and resul
tant histological changes as the natural protein. Availability of larg
e quantities of homogeneous, biologically active recombinant human AFP
will facilitate further studies of structure/function, mechanism, and
therapeutic potential of this agent as a regulator of breast cancer g
rowth.